Anthem Biosciences LTD
₹828.25▼ -13.85 (-1.64%)
ANTHEM·NSE·Healthcare
Market Cap
46330.46 Cr
PE Ratio
78.51
Volume
4,35,144
Day High - Low
843.15 - 819.00
52W High-Low
977.55 - 579.15
₹828.25▼ -13.85 (-1.64%)
Market Cap46330.46 Cr
PE Ratio78.51
Volume4,35,144
Day High - Low843.15 - 819.00
52W High-Low977.55 - 579.15
Anthem Biosciences Ltd (ANTHEM): company summary
The company's business is improving, with annual revenue rising 15.1% and annual net profit growing 31.2%.
Anthem Biosciences Ltd (ANTHEM) is a mid-cap Healthcare company valued at ₹46,330 crore operating in Biotechnology on the NSE and BSE.
- Recent price move
- Anthem Biosciences Ltd last traded at ₹828.25, modestly down 1.64% on the day.
- Recent developments
- On 2026-10-09, the company executed a block deal where Portsmouth Technologies LLC sold 30 lakh shares of Anthem Biosciences at Rs 833 each, totaling Rs 249.90 crore.
- Financial performance
- The company's business is improving, with annual revenue rising 15.1% and annual net profit growing 31.2%. However, the latest quarter saw revenue fall 22.6% compared to the same quarter a year earlier, and net profit dropped 11.8%.
- Valuation multiples
- The stock trades at 78.5 times earnings, a premium to the Healthcare median of 32.0, 17.43 times book value. It yields 0.2%.
- Things to watch
- The company's latest quarter revenue fell 22.6% compared to the same quarter a year earlier, and net profit dropped 11.8%. The stock is 11.8% below its 52-week high.
- Where it stands
- The company's annual revenue and net profit have grown significantly, but the latest quarter results show a decline. The stock is 11.8% below its 52-week high, and promoter holding fell by 3.26 percentage points in the latest quarter.
Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
6.3/10
Fair
Fair Value
Sign in to see
ROE
19.45%
Strong
P/E
78.51x
Expensive
Debt / Equity
0.02
Low
Industry
Healthcare
Biotechnology
Overall View
Mixed
Price performance
NIFTY 500NIFTY MIDCAP 150
Day₹819.00
₹843.15
52W₹579.15
₹977.55
DocStoX take
Supported by risk (9.4) and quality (8.6), but held back by valuation (0.0). Risk looks strong at 9.4, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence6.3
/10
Fair
Quality
Excellent
ROE 19.5%
Valuation
Expensive
P/E 78.5×
Growth
Steady
Revenue +14.0% 5Y CAGR
Risk
Low risk
D/E 0.02
Momentum
Firm
63% of 52-week range
At a glance
Market Cap
₹46,330 Cr
52W High / Low
₹978 / ₹579
Dividend Yield
0.21%
Promoter Holding
71.40%
EPS (TTM)
₹10.55
Book Value
₹54.16
Key highlights
- Low leverage — D/E 0.02
- Profitable in all of the last 5 years
- Healthy net margin (28%)
- Valuation is weak (0.0/10)
- Expensive at 79× earnings
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Biotechnology
Explore ANTHEM BIOSCIENCES LTD’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
ANTHEM BIOSCIENCES LTD peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDLAURUS LABS LIMITEDCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare ANTHEM BIOSCIENCES LTD with peers
Related tools & concepts
Value ANTHEM BIOSCIENCES LTD with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing